1013 related articles for article (PubMed ID: 8231395)
1. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
2. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
Valiente A; Outeriño J; Martín Calderín F; Benítez J
Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
[TBL] [Abstract][Full Text] [Related]
3. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
5. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
6. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
Farhi DC; Luckey CN; Siddiqui AM
Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
[TBL] [Abstract][Full Text] [Related]
7. Detection of BCR/ABL fusion gene in CML: a preliminary report.
Rerkamnuaychoke B; Kangwanpong D; Jootar S; Puranakanitstha C
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():197-200. PubMed ID: 8629106
[TBL] [Abstract][Full Text] [Related]
8. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
Xue YQ
Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.
Berthéas MF; Vindimian M; Ollagnon G; Pomier G; Jaubert J; Vasselon C; Reynaud J; Heally JC; Le Petit JC; Brizard CP
Nouv Rev Fr Hematol (1978); 1989; 31(6):393-5. PubMed ID: 2616268
[TBL] [Abstract][Full Text] [Related]
10. BCR rearrangements in Ph positive chronic myelocytic leukemia.
Deng DS; Yang AD; Gong WL; Fei HB; Liu SM
Chin Med J (Engl); 1991 Aug; 104(8):658-63. PubMed ID: 1680611
[TBL] [Abstract][Full Text] [Related]
11. [Molecular analysis of chronic Philadelphia chromosome negative myeloid leukemia: study of 6 cases].
Cervantes F; Urbano-Ispizua A; Pujades A; Bosch F; Vives-Corrons JL; Montserrat E; Rozman C
Med Clin (Barc); 1992 Sep; 99(8):286-8. PubMed ID: 1453821
[TBL] [Abstract][Full Text] [Related]
12. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
Melo JV; Goldman JM
Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
[TBL] [Abstract][Full Text] [Related]
13. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
14. [BCR and ABL gene rearrangement in chronic myeloid leukemia].
Rypácková B; Haskovec C; Brdicka R
Vnitr Lek; 1993 Oct; 39(10):964-8. PubMed ID: 8236869
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
16. [T lymphoblastic leukemia with leukemoid reaction or the extramedullary blast crisis of Philadelphia chromosome-negative chronic myeloid leukemia? Comments apropos 2 cases].
Tassies D; Feliu E; Villamor N; Urbano-Ispizua A; Cervantes F; Campo E; Ordi J; Vernet M; Pujol R; López R
Med Clin (Barc); 1990 Nov; 95(16):618-20. PubMed ID: 2097454
[TBL] [Abstract][Full Text] [Related]
17. [Masked Philadelphia chromosome: diagnostic implications in a case of chronic myeloid leukemia presenting in blast crisis].
Carrasco JL; Hernández García MT; Otero A; Vilar MC; Marsá L; González Brito G; García Miranda JL; Hernández Nieto L
Sangre (Barc); 1992 Oct; 37(5):395-8. PubMed ID: 1293781
[TBL] [Abstract][Full Text] [Related]
18. [Cytogenetic and molecular aspects of Ph-positive leukemia].
Misawa S; Nishigaki H
Rinsho Ketsueki; 1991 Apr; 32(4):313-8. PubMed ID: 2067072
[TBL] [Abstract][Full Text] [Related]
19. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
20. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
Becher R; Kloke O
Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]